Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Curiosity Diagnostics is a molecular diagnostics company specializing in rapid, high-multiplex point-of-care testing. The company developed the PCR|ONE platform, a sample-to-answer system that utilizes proprietary infrared thermal cycling technology to deliver genetic results in under 20 minutes. Acquired by Bio-Rad Laboratories in 2022 for up to $170 million, Curiosity Diagnostics provides automated solutions for detecting a broad range of pathogens in near-patient settings such as emergency rooms and outpatient clinics. Its portfolio includes CE-marked panels for SARS-CoV-2 and MRSA/MSSA, with ongoing development of multiplex respiratory and sexually transmitted infection panels.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CuriositySteam.